medication: Latest News

October 17, 2024Onyda XR (clonidine hydrochloride), the first and only liquid non-stimulant ADHD medication approved in the U.S., and the only such medication with nighttime dosing, became available nationwide for the treatment of attention deficit hyperactivity disorder (ADHD) on October 1. 1The U.S.

Parents seldom deny it: Summer break comes with its own set of challenges. Sure, those nine months spent cajoling your kids (and maybe even yourself) out of bed and to school on time are over. You survived the late-night homework and test agony.

June 11, 2025Stimulants do not cause psychosis in children, concluded a new study published in Pediatrics.1 The study assuages concerns raised by previous observational research linking the use of stimulants to psychosis, which prompted the Food and Drug Administration (FDA) in 2007 to add a warning label to stimulants.2 The new study demonstrated that the slight association between stimulant use and psychosis is correlated to other factors, including the severity of ADHD symptoms, and not caused by the medications.The research team, led by Ian Kelleher, M.D., chair of child and adolescent psychiatry at the University of Edinburgh in the U.K, used data from the Adolescent Brain Cognitive Development Study, a longitudinal study that followed 8,391 children ages 9 to 14, for a year. Of these children, 5.5% were taking stimulant medication for ADHD.Among both the general population and children taking stimulants, the risk of having a psychotic episode was very low.

People are being urged to respect the limitation of 30-day prescription refills because it is a “necessary measure to protect the drug supply for all,” says the New Brunswick Pharmacists’ Association and New Brunswick Medical Society.

Andrew Forgione, a spokesperson for the drug wholesaler McKesson, said the company was working with pharmacies, hospitals and manufacturing partners to promote responsible ordering and distribution during the novel coronavirus pandemic and COVID-19 outbreak.